The team at Cooley LLP counts technological and pharmaceutical companies among its key clients. Patrick Gibbs heads the team from Palo Alto, with an eye on securities class actions and derivative litigation, SEC investigations and enforcement proceedings. San Diego-based Koji Fukumura is a go-to for pharmaceutical clients, and, in Boston, Luke Cadigan is a key contact for business litigation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘I consider Cooley to be a first-tier global litigation firm suitable for bet-the-company type disputes.’
Key clients
- NVIDIA
- IONQ
- Revance Therapeutics
- Freshworks
- Cantor Fitzgerald
- Talphera
- Scynexis
- Illumina
- SPOSC Investment Holdings, LLC
- Malibu Boats
- Outlook Therapeutics
- FIGS
Work highlights
Representing NVIDIA in a major securities class action arising from a significant stock drop tied to allegations regarding the impact of cryptomining on its gaming business.
Represented IonQ in a securities class action arising from allegations tied to its SPAC merger.
Represented Revance Therapeutics in a securities class action alleging the company misled investors regarding the FDA approval prospects of its neuromodulator treatment, DAXXIFY®. Cooley secured dismissal with prejudice in the Northern District of California, including striking an expert declaration submitted by plaintiffs.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Patrick Gibbs
Other key lawyers
Koji Fukumura; Luke Cadigan; Shannon Eagan; Ryan Blair; Peter Adams; Tijana Brien